The university hospital of Heidelberg is one of the largest medical centers in the Federal Republic of Germany behind the Charité in Berlin and the LMU Klinikum in Munich.

There are 1,900 (2012) beds in University Hospital Heidelberg.

During the past decade, University Hospital Heidelberg conducted 93 clinical trials. In the 10-year time frame, 93 clinical trials started and 13 clinical trials were completed, i.e. on average, 14% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 6 clinical trials were completed. i.e. 12.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Heidelberg" #1 sponsor was "University Hospital Heidelberg" with 36 trials, followed by "Heidelberg University" with 15 trials sponsored, "University of Heidelberg Medical Center" with 7 trials sponsored, "European Myeloma Network" with 3 trials sponsored and "European Society for Blood and Marrow Transplantation" with 3 trials sponsored. Other sponsors include 80 different institutions and companies that sponsored additional 73 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Heidelberg" #1 collaborator was "University Hospital Heidelberg" with 6 trials as a collaborator, "University Hospital Erlangen" with 4 trials as a collaborator, "German Cancer Research Center" with 3 trials as a collaborator, "Hannover Medical School" with 3 trials as a collaborator and "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include 161 different institutions and companies that were collaborators in the rest 158 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Heidelberg" are "Ischemic Stroke" (5 trials), "Atrial Fibrillation" (3 trials), "Crohn's Disease" (3 trials), "Drug Interactions" (3 trials) and "Head and Neck Cancer" (3 trials). Many other conditions were trialed in "University Hospital Heidelberg" in a lesser frequency.

Most popular intervention types in "University Hospital Heidelberg" are "Drug" (53 trials), "Other" (28 trials), "Device" (23 trials), "Procedure" (12 trials) and "Behavioral" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Blood sampling" (2 trials), "Copegus®" (2 trials), "Cyclophosphamide" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Heidelberg" are 144 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are 58 active trials in "University Hospital Heidelberg". 2 are not yet recruiting, 37 are recruiting, 17 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 64 completed trials in University Hospital Heidelberg, 2 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Heidelberg, 6 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 41 trials that are defined as “Not Applicable".

University Hospital Heidelberg has several departments that took part in Clinical trials: "Sports Medicine, University Hospital" - 9 trials, "University Children's Hospital Heidelberg, Cystic Fibrosis Centre" - 5 trials, "University Children's Hospital" - 4 trials, "Department of Cardiology - University Hospital of Heidelberg" - 4 trials, "University Hospital of Heidelberg, Radiation Oncology" - 31 trials, "University Breast Unit, Department of Gynecology, University of Heidelberg" - 2 trials, "Department of Neurosurgery, University Hospital Heidelberg" - 2 trials, "Spinal Cord Injury Center | Heidelberg University Hospital" - 2 trials, "University of Heidelberg, Department of Cardiology" - 2 trials